Biotech's Boom Suffers a Setback in March April 01, 2014 | Press Release
Investors Flock to Biotech March 03, 2014 | Press Release
Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press ReleaseSee all News
Mary TannerSenior Managing Director, Burrill Securities
Mary Tanner, former Senior Managing Director at both Lehman Brothers and Bear Stearns and co-founder and Managing Partner of Life Sciences Partners, LLC, a financial advisory firm, joined Burrill & Company as Senior Managing Director of both Burrill & Company and Burrill Securities.
At Life Sciences Partners, Tanner specializes in healthcare investment and strategic advisory work. Now associated with Burrill & Company, Life Sciences Partners concentrates on strategy and financial advice to life sciences companies, complementing Burrill & Company’s investment banking and principal investing businesses.
Previously, Tanner served as Senior Managing Director at Lehman Brothers and Bear Stearns, and as a Managing Director of Peter J. Solomon Company. Tanner has devoted more than 25 years to the global healthcare industry. Her expertise includes the ethical pharmaceutical industry, biotechnology, diagnostics, medical devices, healthcare services, cosmetics and consumer medicine industries. In addition to her well-known work with large companies, she specializes in domestic and cross-border transactions between large and small companies, including corporate partnering and minority investments. Tanner’s clients have included Pfizer in its $60 billion acquisition of Pharmacia, Amgen in its $16 billion acquisition of Immunex, Rhône-Poulenc in its acquisition of Rorer, followed by Rhône-Poulenc Rorer in its acquisition of U.K. company Fisons, and BASF/ BASF Pharma, in its acquisition of U.K. Boots Pharmaceuticals.
Tanner received a B.A. from Harvard University.